Organization
Center for Immuno-Oncology, Center for Cancer Research, NCI, NIH, Bethesda, MD
7 abstracts
1 poster
Abstract
Triplet combination treatments with pembrolizumab (pembro) for anti–PD-(L)1–refractory advanced melanoma: Preliminary results of the phase 1/2 KEYMAKER-U02A study.Org: University Hospital Zurich, Aix-Marseille University CHU Timone, Hôpital de la Timone, Department of Cancer Medicine, Gustave Roussy Cancer Centre, Gustave Roussy Cancer Campus,
Abstract
Genomic and immune profiling of rare non-squamous sinonasal tumors.Org: Winship Cancer Institute, Emory University School of Medicine, Emory University, Atlanta, GA, USA, Caris Life Sciences, Irving, TX, Department of Otolaryngology Head and Neck Surgery, Emory University Hospital Midtown,
Abstract
Characterization of enhancer of zeste homolog 2 (EZH2) expression, activity, and association with the tumor immune microenvironment in olfactory neuroblastoma (ONB).Org: Caris Life Sciences, Irving, TX, University of Maryland Marlene and Stewart Greenebaum Cancer Center, Huntsman Cancer Institute, Lombardi Comprehensive Cancer Center, Hunstman Cancer Hospital, University of Utah Health,
Abstract
A phase I study of bintrafusp alfa and NHS-IL12 (M9241) alone and in combination with stereotactic body radiation therapy (SBRT) in patients with metastatic genitourinary (GU) malignancies.Org: Center for Cancer Research, National Cancer Institute, National Cancer Institute, Vilnius, Lithuania, National Institutes of Health All of Us Research Program, NYU Langone Laura and Isaac Perlmutter Cancer Center, Genitourinary Malignancies Branch,
Abstract
Nominating molecular/immunologic drivers of central nervous system (CNS) metastases in squamous cell carcinoma of the head/neck (SCCHN).Org: Pritzker School of Medicine, The University of Chicago Medicine Center for Advanced Care at Orland Park, MD Anderson Hematology/Oncology Fellowship, Canter for Head and Neck Oncology, Dana-Farber Cancer Institute,
Abstract
Older adults (OA) in clinical trials: Where are they? Representation of OA in clinical trials conducted at the National Cancer Institute (NCI) Clinical Center.Org: Genitourinary Malignancies Branch, CCRT/The Caroline Foundation, NCI, Nihon Medi-Physics, Medical Oncology Service,
Abstract
Mass cytometry immune profiling to detect signatures of clinical activity of bintrafusp alfa (BA) in patients with advanced non-small cell lung cancer (NSCLC).Org: Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Cancer Institute, Vilnius, Lithuania, National Institutes of Health All of Us Research Program, Teiko Bio,